Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106946664A reveals a high-purity stabilizer synthesis. This method offers supply chain reliability and cost reduction for energetic material manufacturing.
Patent CN104277018B enables high-purity 2 5-dimethylaminofuran production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103539702A reveals a greener route for N'-aryl-N,N-dimethylformamidine synthesis, enabling cost reduction in API manufacturing for oncology drugs like Erlotinib.
Patent CN117362252B details a bio-based furan route to FDCM. Offers safer Claisen reaction and scalable polymer intermediate production for global supply chains.
Patent CN114230525B reveals a high-yield, eco-friendly synthesis route for 2-amino-4,6-dimethoxypyrimidine, eliminating phosphorus waste and reducing operational complexity for global supply chains.
Novel resolution method for levodopa intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing needs.
Novel 1,8-naphthalimide derivative with reduced toxicity for lung cancer treatment. Efficient synthesis offers supply chain stability and cost advantages.
Patent CN102863335A reveals a green one-step synthesis for succinic acid diesters using CO2. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102093399B reveals stable boronation reagent synthesis. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing.
Novel one-pot Grignard method for alkyl phenylboronic acid reduces cost and time. Ideal for high-purity pharmaceutical and agrochemical intermediate manufacturing.
Patent CN115108932A reveals a novel Ru-catalyzed oxidative amidation using DMF. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel salt formation method removes dicarboxylic acid impurity ensuring high purity and yield for scalable antihypertensive drug manufacturing.
Patent CN108752178B reveals a high-yield Grignard-based route for decarene aldehyde, offering significant cost reduction and supply chain stability for carotenoid manufacturers.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Novel Penicillium-derived monoamine oxidase enables high-concentration biocatalysis for antiviral drug intermediates, ensuring supply chain stability and cost efficiency.
Patent CN107954976B details a catalyst-free decarboxylation route for 3,4-dimethoxy-thiophene. This method ensures high purity and significant cost reduction for electronic chemical manufacturing supply chains.
Patent CN102267944A reveals a cost-effective route for Dimemorfan Phosphate intermediates using commodity raw materials, ensuring high purity and supply stability.
Patent CN104080791B details CO2 isolation for boronates. Enhances purity and solvent recovery for scalable agrochemical intermediate supply chains.
Novel synthesis method for propellant stabilizer offers higher yield and purity. Reduces solvent costs and simplifies operation for reliable supply chain.
Novel synthesis route for Baculiferin L intermediate. Cost-effective, scalable, high-purity pharmaceutical intermediate manufacturing process.